Isomorphic Labs Appoints Dr. Ben Wolf as Chief Medical Officer
Isomorphic Labs has appointed Dr. Ben Wolf as Chief Medical Officer and established a new US presence in Cambridge, Massachusetts, announced in a press release. Dr. Wolf, who brings nearly 20 years of biopharmaceutical experience, will lead the company's efforts in translating AI-driven drug discoveries into medicines.
Dr. Wolf will be based in the newly established Cambridge location, which will serve as a key operational hub. This expansion follows the company's recent $600 million funding round, aimed at advancing its AI drug design engine. Dr. Wolf's previous roles include Chief Medical Officer at Relay Therapeutics and KSQ Therapeutics, where he led clinical trials and advanced therapeutic pipelines.
The appointment of Dr. Wolf and the establishment of the US presence underscore Isomorphic Labs' commitment to leveraging AI for drug discovery and development. The Cambridge hub will work closely with teams in London and Lausanne, enhancing the company's global operations.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Prologue Medicines names Stephen Harrison chief scientific officer
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
Notable Names Nicholas Desai Chief Medical Officer
Basecamp Research Raises $140 Million for AI Designed Therapeutics
INmune Bio and QCi Apply Quantum Computing to XPro Research
Daily AI Brief: the AI news that matters, in your inbox.